PL343710A1 - Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine - Google Patents

Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine

Info

Publication number: PL343710A1
Authority: PL; Poland
Prior art keywords: abacavir; lamivudine; zidovudine; pharmaceutical compositions; homogeneous pharmaceutical
Prior art date: 1998-04-29

Application number

PL99343710A

Other languages

English (en)

Inventor

Robin Currie

Sunil Jain

Allen Wayne Wood

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-29

Filing date

1999-04-26

Publication date

2001-08-27

1999-04-26 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2001-08-27 Publication of PL343710A1 publication Critical patent/PL343710A1/xx

Links

LHCOVOKZWQYODM-CPEOKENHSA-N 4-amino-1-[(2r,5s)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one;1-[(2r,4s,5s)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1.O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 LHCOVOKZWQYODM-CPEOKENHSA-N 0.000 title 1
229960004748 abacavir Drugs 0.000 title 1
MCGSCOLBFJQGHM-SCZZXKLOSA-N abacavir Chemical compound C=12N=CN([C@H]3C=C[C@@H](CO)C3)C2=NC(N)=NC=1NC1CC1 MCGSCOLBFJQGHM-SCZZXKLOSA-N 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Inorganic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Tropical Medicine & Parasitology (AREA)
Communicable Diseases (AREA)
Bioinformatics & Cheminformatics (AREA)
AIDS & HIV (AREA)
Biophysics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL99343710A 1998-04-29 1999-04-26 Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine PL343710A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9809213.3A GB9809213D0 (en)	1998-04-29	1998-04-29	Pharmaceutical compositions
PCT/EP1999/002794 WO1999055372A1 (en)	1998-04-29	1999-04-26	Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine

Publications (1)

Publication Number	Publication Date
PL343710A1 true PL343710A1 (en)	2001-08-27

Family

ID=10831228

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL99343710A PL343710A1 (en)	1998-04-29	1999-04-26	Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine

Country Status (23)

Country	Link
EP (1)	EP1083932A1 (id)
JP (1)	JP2002512979A (id)
KR (1)	KR20010043128A (id)
CN (1)	CN1411380A (id)
AP (1)	AP2000001971A0 (id)
AU (1)	AU4135599A (id)
BR (1)	BR9910071A (id)
CA (1)	CA2330391A1 (id)
EA (1)	EA200000997A1 (id)
EE (1)	EE200000646A (id)
GB (1)	GB9809213D0 (id)
HR (1)	HRP20000732A2 (id)
HU (1)	HUP0101622A3 (id)
ID (1)	ID26955A (id)
IL (1)	IL139181A0 (id)
IS (1)	IS5675A (id)
NO (1)	NO20005418L (id)
NZ (1)	NZ507745A (id)
PL (1)	PL343710A1 (id)
SK (1)	SK16212000A3 (id)
TR (1)	TR200003157T2 (id)
WO (1)	WO1999055372A1 (id)
ZA (1)	ZA200005922B (id)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6875773B1 (en)	1998-05-29	2005-04-05	Ben M. Dunn	Combination therapy for treatment of FIV infection
CA2374198A1 (en) *	1998-05-29	1999-12-02	Maki Arai	Combination therapy for treatment of fiv infection
GB9820417D0 (en) *	1998-09-18	1998-11-11	Glaxo Group Ltd	Antiviral combinations
US7074417B2 (en) *	2000-10-13	2006-07-11	Advancis Pharmaceutical Corporation	Multiple-delayed release anti-viral product, use and formulation thereof
DE60219965T2 (de) *	2002-04-23	2008-01-17	Lupin Ltd., Mumbai	Lang wirkende zusammensetzungen enthaltend zidovudine und/oder lamivudine
AR040242A1 (es) *	2002-06-04	2005-03-23	Glaxo Group Ltd	Composiciones farmaceuticas
CN100335125C (zh) *	2003-06-03	2007-09-05	上海现代药物制剂工程研究中心	杀毒抗菌用长效干扰素喷鼻粉剂
US20110104267A1 (en) *	2005-04-25	2011-05-05	Aurobindo Pharma Limited	Pharmaceutical compositions of antiretrovirals
WO2007013047A2 (en) *	2005-07-29	2007-02-01	Ranbaxy Laboratories Limited	Water-dispersible anti-retroviral pharmaceutical compositions
ES2279707B1 (es) *	2005-11-10	2008-06-01	Combino Pharm, S.L.	Formulaciones orales que comprenden 3'-azidonucleosidos.
CN101878032A (zh) *	2007-10-02	2010-11-03	埃默里大学	齐多夫定和针对hiv聚合酶中k65r突变选择的药剂的强力组合
WO2009092002A1 (en) *	2008-01-17	2009-07-23	Duquesne University Of The Holy Spirit	Antiretroviral drug formulations for treatment of children exposed to hiv/aids
UA105556C2 (uk) *	2010-01-27	2014-05-26	Віів Гелскер Компані	Комбінація сполук, що містить інгібітори віл інтегрази з іншими терапевтичними агентами
CN104203275A (zh)	2010-06-09	2014-12-10	疫苗技术股份有限公司	用于增强抗逆转录病毒治疗的hiv感染者的治疗性免疫
IN2014MN01907A (id)	2012-03-05	2015-07-10	Cipla Ltd
US10004721B2 (en)	2012-10-23	2018-06-26	Cipla Limited	Pharmaceutical antiretroviral composition
SMT202400092T1 (it)	2013-06-13	2024-05-14	Akebia Therapeutics Inc	Composizioni e metodi per il trattamento dell'anemia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY115461A (en) *	1995-03-30	2003-06-30	Wellcome Found	Synergistic combinations of zidovudine, 1592u89 and 3tc
GB9622681D0 (en) *	1996-10-31	1997-01-08	Glaxo Group Ltd	Pharmaceutical compositions

1998
- 1998-04-29 GB GBGB9809213.3A patent/GB9809213D0/en not_active Ceased
1999
- 1999-04-26 IL IL13918199A patent/IL139181A0/xx unknown
- 1999-04-26 HR HR20000732A patent/HRP20000732A2/hr not_active Application Discontinuation
- 1999-04-26 JP JP2000545569A patent/JP2002512979A/ja active Pending
- 1999-04-26 ID IDW20002479A patent/ID26955A/id unknown
- 1999-04-26 TR TR2000/03157T patent/TR200003157T2/xx unknown
- 1999-04-26 PL PL99343710A patent/PL343710A1/xx unknown
- 1999-04-26 CA CA002330391A patent/CA2330391A1/en not_active Abandoned
- 1999-04-26 NZ NZ507745A patent/NZ507745A/en unknown
- 1999-04-26 BR BR9910071-1A patent/BR9910071A/pt not_active IP Right Cessation
- 1999-04-26 SK SK1621-2000A patent/SK16212000A3/sk unknown
- 1999-04-26 EA EA200000997A patent/EA200000997A1/ru unknown
- 1999-04-26 CN CN99807983A patent/CN1411380A/zh active Pending
- 1999-04-26 EP EP99924822A patent/EP1083932A1/en not_active Withdrawn
- 1999-04-26 KR KR1020007012021A patent/KR20010043128A/ko not_active Withdrawn
- 1999-04-26 EE EEP200000646A patent/EE200000646A/xx unknown
- 1999-04-26 AP APAP/P/2000/001971A patent/AP2000001971A0/en unknown
- 1999-04-26 HU HU0101622A patent/HUP0101622A3/hu unknown
- 1999-04-26 AU AU41355/99A patent/AU4135599A/en not_active Abandoned
- 1999-04-26 WO PCT/EP1999/002794 patent/WO1999055372A1/en not_active Ceased
2000
- 2000-10-20 IS IS5675A patent/IS5675A/is unknown
- 2000-10-23 ZA ZA200005922A patent/ZA200005922B/xx unknown
- 2000-10-27 NO NO20005418A patent/NO20005418L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ZA200005922B (en)	2001-10-23
CA2330391A1 (en)	1999-11-04
ID26955A (id)	2001-02-22
NO20005418L (no)	2000-11-29
HRP20000732A2 (en)	2001-02-28
EA200000997A1 (ru)	2001-06-25
EE200000646A (et)	2002-04-15
HUP0101622A2 (hu)	2002-03-28
JP2002512979A (ja)	2002-05-08
NZ507745A (en)	2004-07-30
WO1999055372A1 (en)	1999-11-04
EP1083932A1 (en)	2001-03-21
SK16212000A3 (sk)	2001-07-10
NO20005418D0 (no)	2000-10-27
HUP0101622A3 (en)	2003-09-29
BR9910071A (pt)	2000-12-26
TR200003157T2 (tr)	2001-01-22
GB9809213D0 (en)	1998-07-01
CN1411380A (zh)	2003-04-16
IS5675A (is)	2000-10-20
AU4135599A (en)	1999-11-16
KR20010043128A (ko)	2001-05-25
IL139181A0 (en)	2001-11-25
AP2000001971A0 (en)	2000-12-31

Publication	Publication Date	Title
HU9901606D0 (en)	1999-07-28	Pharmaceutical compositions
HUP0103507A3 (en)	2002-05-28	Pharmaceutical compositions comprising 2-quinolones
HUP0001186A3 (en)	2002-04-29	Purine l-nucleosides,analogs and pharmaceutical compositions thereof
PL336840A1 (en)	2000-07-17	Hair-care composition
HUP0101622A3 (en)	2003-09-29	Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine
HUP0104489A3 (en)	2004-05-28	Stabilizated macrolides and pharmaceutical compositions containing them
PT1466615E (pt)	2009-09-07	Composição farmacêutica
PL343627A1 (en)	2001-08-27	Medicinal compositions
GB9804469D0 (en)	1998-04-29	Antiviral composition
TW385760U (en)	2000-03-21	Pen
ZA200005510B (en)	2001-05-08	Pharmaceutical composition.
GB9818591D0 (en)	1998-10-21	Pharmaceutical composition
HUP0104834A3 (en)	2005-06-28	Sulphonyloxazolamines, their use, pharmaceutical compositions containing them and their preparation
CY2485B1 (en)	2005-06-03	Pharmaceutical compositions containing lamivudine and zidovudine.
HK1034188A (en)	2001-10-19	Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine
HUP9903098A3 (en)	2000-01-28	Combination comprising vx478, zidovudine and/or 1592u89 and pharmaceutical composition containing them
AU6085099A (en)	2000-04-10	Antiviral combinations comprising lamivudine and abacavir
AU4419197A (en)	1999-04-05	Structured high moisture solid compositions with improved physical properties
HUP0103006A3 (en)	2002-12-28	Substituted betha-diketones, pharmaceutical compositions containing them and their use
ZA997202B (en)	2000-05-08	Pharmaceutical composition.
GB9828707D0 (en)	1999-02-17	Pharmaceutical uses
HK1035865A (en)	2001-12-14	Antiviral combinations comprising lamivudine and abacavir
CA84183S (en)	1998-06-26	Pen
TW386492U (en)	2000-04-01	Pen structure
IL137210A0 (en)	2001-07-24	Pharmaceutical compositions comprising thiram